HU9402925D0 - Vew use of beta-carbolines - Google Patents
Vew use of beta-carbolinesInfo
- Publication number
- HU9402925D0 HU9402925D0 HU9402925A HU9402925A HU9402925D0 HU 9402925 D0 HU9402925 D0 HU 9402925D0 HU 9402925 A HU9402925 A HU 9402925A HU 9402925 A HU9402925 A HU 9402925A HU 9402925 D0 HU9402925 D0 HU 9402925D0
- Authority
- HU
- Hungary
- Prior art keywords
- vew
- carbolines
- beta
- vew use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4212529A DE4212529A1 (en) | 1992-04-10 | 1992-04-10 | Use of µ-carbolines as non-competitive glutamate antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9402925D0 true HU9402925D0 (en) | 1995-01-30 |
| HUT68212A HUT68212A (en) | 1995-06-28 |
Family
ID=6456829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9402925A HUT68212A (en) | 1992-04-10 | 1993-04-06 | Process for producing new beta-carbolines and pharmaceutical compositions which are applicable for treatment of neurological and psychiatric disorders and containing beta-carbolines |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0633779A1 (en) |
| JP (1) | JPH07505404A (en) |
| KR (1) | KR950700739A (en) |
| CA (1) | CA2117755A1 (en) |
| DE (1) | DE4212529A1 (en) |
| FI (1) | FI944714A (en) |
| HU (1) | HUT68212A (en) |
| IL (1) | IL105349A0 (en) |
| WO (1) | WO1993020820A1 (en) |
| ZA (1) | ZA932553B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330175A1 (en) * | 1993-08-31 | 1995-03-02 | Schering Ag | Alkoxy substituted beta carbolines |
| DE4436190A1 (en) * | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenated β-carboline derivatives, process for their preparation and use of these substances for inhibiting the respiratory chain |
| RU2106864C1 (en) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | New approach to treatment of alzheimer's disease |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| HUP0001062A3 (en) | 1996-09-27 | 2001-09-28 | Guilford Pharmaceuticals Inc B | Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity |
| WO2006133391A2 (en) * | 2005-06-06 | 2006-12-14 | Fibrogen, Inc. | Improved treatment for anemia using a hif-alpha stabilising agent |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3540653A1 (en) * | 1985-11-13 | 1987-05-14 | Schering Ag | NEW 3-OXADIAZOLE AND 3-CARBONIC ACID SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
| DE3545776A1 (en) * | 1985-12-20 | 1987-06-25 | Schering Ag | 5-AMINOALKYL-SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
-
1992
- 1992-04-10 DE DE4212529A patent/DE4212529A1/en not_active Withdrawn
-
1993
- 1993-04-06 WO PCT/EP1993/000858 patent/WO1993020820A1/en not_active Application Discontinuation
- 1993-04-06 JP JP5517954A patent/JPH07505404A/en active Pending
- 1993-04-06 HU HU9402925A patent/HUT68212A/en unknown
- 1993-04-06 CA CA002117755A patent/CA2117755A1/en not_active Abandoned
- 1993-04-06 EP EP93908924A patent/EP0633779A1/en not_active Withdrawn
- 1993-04-08 ZA ZA932553A patent/ZA932553B/en unknown
- 1993-04-09 IL IL105349A patent/IL105349A0/en unknown
-
1994
- 1994-10-07 FI FI944714A patent/FI944714A/en not_active Application Discontinuation
- 1994-10-08 KR KR1019940703566A patent/KR950700739A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0633779A1 (en) | 1995-01-18 |
| IL105349A0 (en) | 1993-08-18 |
| KR950700739A (en) | 1995-02-20 |
| FI944714A0 (en) | 1994-10-07 |
| WO1993020820A1 (en) | 1993-10-28 |
| JPH07505404A (en) | 1995-06-15 |
| ZA932553B (en) | 1993-11-02 |
| DE4212529A1 (en) | 1993-10-14 |
| CA2117755A1 (en) | 1993-10-11 |
| HUT68212A (en) | 1995-06-28 |
| FI944714A (en) | 1994-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU117975S (en) | Set of containers | |
| HU9303601D0 (en) | Imidazopyridine | |
| AU115927S (en) | Ring | |
| HU9302059D0 (en) | Differentiating factor of megacaryocyte | |
| HK1001330A1 (en) | Purification of fluoropolymers | |
| IL103349A0 (en) | Ring | |
| ZA942543B (en) | Tetrohydro beta-carbolines | |
| HU9402925D0 (en) | Vew use of beta-carbolines | |
| GB9305605D0 (en) | Apparatus of accomplishing autoport selection | |
| ZA932459B (en) | Imidazopyridines | |
| GB9222985D0 (en) | Use of the tarchonanthus camphoratus | |
| ZA937875B (en) | Imidazopyridines | |
| ZA934243B (en) | Separation of unsaturates | |
| EP0553954A3 (en) | Preparation of tetramethyldiamino-polyoxyethylenes | |
| ZA931368B (en) | Sulphonylbenzyl-substituted imidazopyridines | |
| GB9220894D0 (en) | New use of the pyrazolopyridine compound | |
| IL105369A0 (en) | Process and intermediates for the preparation of 2-amino-5-methyl-pyridine | |
| GB9212264D0 (en) | New use of the pyrazolopyridine compound | |
| GB9215794D0 (en) | New use of the pyrazolopyridine compound | |
| CA71834S (en) | Set of containers | |
| GB9203348D0 (en) | New use of wf13533 substance | |
| GB9223098D0 (en) | Electro-analysis of liquids | |
| GB9217628D0 (en) | Use of rapamycin | |
| GB9205486D0 (en) | Spraying of liquids | |
| GB9219000D0 (en) | Spraying of liquids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |